PAREMYD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Paremyd, and when can generic versions of Paremyd launch?
Paremyd is a drug marketed by Epic Pharma Llc and is included in one NDA.
The generic ingredient in PAREMYD is hydroxyamphetamine hydrobromide; tropicamide. There are two drug master file entries for this compound. Additional details are available on the hydroxyamphetamine hydrobromide; tropicamide profile page.
Summary for PAREMYD
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 110 |
Clinical Trials: | 3 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PAREMYD |
What excipients (inactive ingredients) are in PAREMYD? | PAREMYD excipients list |
DailyMed Link: | PAREMYD at DailyMed |
Recent Clinical Trials for PAREMYD
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ocuphire Pharma, Inc. | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for PAREMYD
US Patents and Regulatory Information for PAREMYD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epic Pharma Llc | PAREMYD | hydroxyamphetamine hydrobromide; tropicamide | SOLUTION/DROPS;OPHTHALMIC | 019261-001 | Jan 30, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |